Global Pharmaceutical Company Tabs Thought Leader Select for Gastroenterology Key Opinion Leader Partnership

June 21, 2012 · Leave a comment

June 21, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in gastroenterology with a top 10 global biopharmaceutical company.

The company, part of a select group of global leaders in drug development for products treating exocrine pancreatic insufficiency (EPI), approached Thought Leader Select for support with scientific advisory boards in support of a new product initiative.  To meet the strategic needs of the company’s advisory board activities in support of the new treatment, Thought Leader Select will deploy its in-house research group for an assessment of community-based key opinion leaders in gastroenterology throughout the United States.

Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in multiple areas where they advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.

For the national assessment, the Thought Leader Select research group will collaborate with a team of national key opinion leaders in gastroenterology to identify community-based physicians for grassroots-level scientific advisory work. Thought Leader Select will combine the key opinion leader recommendations with the experience data to optimize a pool of leading physicians with broad representation across multiple geographic ... read more »

TAGS:                                             

Top 30 Global Biopharmaceutical Company Chooses Thought Leader Select for Blood Disorder KOL Partnership

June 14, 2012 · Leave a comment

June 14, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a global engagement in blood disorders with a top 30 global biopharmaceutical company.

The biopharmaceutical company, part of a select group of global leaders in drug development for a product in development to treat iron overload in the body, approached Thought Leader Select for support with its launch activities across multiple global markets.  To meet the strategic needs of the company’s pre-launch for a new blood disorders treatment, Thought Leader Select will deploy its in-house research group for an assessment of key opinion leaders in the area of chelation therapy.

Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following geographic areas:

  • United States
  • Europe
  • Japan
  • Pacific Rim
  • Middle East

For the global assessment, the Thought Leader Select research group will identify 100 physicians appropriate for compliant engagement in support of drug development for blood disorders.

In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought ... read more »

TAGS: